NIPH Clinical Trials Search

UMIN ID: UMIN000002343

Registered date:17/08/2009

Randomized phase II clinical study on preventive effects of GPS, healthy food on the incidence of infection cases in stomach and colon cancer patients before and after the abdominal surgery

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedstomach and colon cancer patients
Date of first enrollment2009/06/01
Target sample size200
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)GPS group 250mg of GPS (a cupsel contain 125mg of GPS) are orally taken continuously for 3 days before operation and for 27days after opperation.


Primary Outcomeincidence of Surgical Site Infection
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1. Sevier compromised patient(more than PS3) 2. Patient of SHOWKAKAN KYOUSAKU or breading 3. SHINKOUSEI infectious patient 4. Urgent operation patient 5. ZOUKIFUZEN patient 6. Uncontrollable patients together with diabetes mellitus and treated with insulin 7. Suspected cases allergic to yeasts 8. Patient who has been treated with chemotherapy 9. Other patients who are considered to be ruled out by the doctor concerned

Related Information


public contact
Name Tsunesuke Kajimoto, Ph.D.
Address 2-3-26 Kudanminami,Chiyoda-ku,Tokyo 102-00074,Japan Japan
Telephone 03-5276-0212
Affiliation Nippon Biothera Co., Ltd. Healthcare Division
scientific contact
Name Professor Kenji Ogawa
Address 2-1-10 Nishioku,akawa-ku,Tokyo 1160-8567,Japan Japan
Telephone 03-3810-1111
Affiliation Tokyo wemen college of medicine, East clinical center Surgicaldepartment